|
INSM | Insmed Inc |
|
|
INSM | Insmed Inc |
| Pharmaceutical Preparations |
| Book value per $ invested | $ 0.04 |
| Leverage | 63.97% |
| Market Cap | $ 18.6B |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -871.7m |
| Margin | -77.07% |
Insmed Incorporated, a biopharmaceutical company, develops and markets therapies for patients with rare and serious diseases. The company is headquartered in Bridgewater, New Jersey.